- Trials with a EudraCT protocol (382)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (0)
382 result(s) found for: Birth order.
Displaying page 4 of 20.
EudraCT Number: 2007-004757-28 | Sponsor Protocol Number: RR07/8350 | Start Date*: 2009-03-02 | |||||||||||
Sponsor Name:University of Leeds | |||||||||||||
Full Title: A randomised controlled single-blind trial to compare intensive management vs standard care in early psoriatic arthritis | |||||||||||||
Medical condition: Newly diagnosed psoriatic arthritis of less than two years symptom duration | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2007-005367-10 | Sponsor Protocol Number: CRAF265A2101 | Start Date*: 2009-05-18 | |||||||||||
Sponsor Name:Novartis Pharma Services AG | |||||||||||||
Full Title: A Phase I/II, open-label, dose escalation trial to evaluate the safety, pharmacokinetics, and pharmacodynamics of RAF265 (CHIR-265) administered orally to patients with locally advanced or metastat... | |||||||||||||
Medical condition: local advanced or metastatic melanoma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: NL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-002235-25 | Sponsor Protocol Number: A1481131 | Start Date*: 2006-12-14 | |||||||||||
Sponsor Name:Pfizer Ltd, Ramsgate Rd, Sandwich, Kent, United Kingdom | |||||||||||||
Full Title: A Randomized, Double-Blind, Placebo Controlled, Dose Ranging, Parallel Group Study of Oral Sildenafil in the Treatment of Children, Aged 1-17 Years, With Pulmonary Arterial Hypertension | |||||||||||||
Medical condition: Pulmonary Arterial Hypertension | |||||||||||||
|
|||||||||||||
Population Age: Infants and toddlers, Children, Adolescents, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Completed) FI (Prematurely Ended) SK (Completed) Outside EU/EEA | |||||||||||||
Trial results: View results |
EudraCT Number: 2004-004314-16 | Sponsor Protocol Number: 1 R01 NS45109-01A1 | Start Date*: 2005-04-25 |
Sponsor Name:NINDS | ||
Full Title: Ensayo multicéntrico de tratamiento de la hipotiroxinemia transitoria en los niños <= 1000 gr de peso al nacimiento o <= 28 semanas de gestación y seguimiento del desarrollo psicomotor hasta los 5 ... | ||
Medical condition: The aims of the study are to compare two dosing levels and the mode of administration of thyroid hormones or iodine supplementation in premature infants to achieve optimal plasma hormone targets. T... | ||
Disease: | ||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2014-002833-70 | Sponsor Protocol Number: s56892 | Start Date*: 2014-12-18 |
Sponsor Name:UZLeuven | ||
Full Title: Radium-223 in patients with PSA progression and without clinical metastases following maximal local therapy: a pilot study | ||
Medical condition: Patients with prostate cancer (PCa) who experience PSA progression and who are without detectable metastases following maximal local treatment consisting of radical prostatectomy (RP) + pelvic l... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male | |
Trial protocol: BE (Completed) | ||
Trial results: View results |
EudraCT Number: 2004-004149-16 | Sponsor Protocol Number: H3E-ES-S085 | Start Date*: 2005-02-16 |
Sponsor Name:Lilly S.A. | ||
Full Title: Phase 1/2 Study of Biweekly ALIMTA plus Cisplatin in patients with Locally Advanced, non-Resectable or Metastatic Urothelial Cancer | ||
Medical condition: Locally Advanced, non-Resectable or Metastatic Urothelial Cancer | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2005-001193-28 | Sponsor Protocol Number: AMB-320/321-E | Start Date*: 2005-11-08 |
Sponsor Name:Myogen, Inc | ||
Full Title: ARIES-320/321-E “A Long-Term Study of Ambrisentan in Pulmonary Arterial Hypertension Subjects Having Completed AMB-320 or AMB-321" | ||
Medical condition: Pulmonary Arterial Hypertension | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Completed) | ||
Trial results: View results |
EudraCT Number: 2006-004595-13 | Sponsor Protocol Number: BAY59-7939/11630 | Start Date*: 2009-03-09 | |||||||||||
Sponsor Name:Bayer HealthCare AG | |||||||||||||
Full Title: A Prospective, Randomized, Double-Blind, Double-Dummy, Parallel-Group, Multicenter, Event-Driven, Non-inferiority Study Comparing the Efficacy and Safety of Once Daily Oral Rivaroxaban (BAY 59-7939... | |||||||||||||
Medical condition: Prevention of Stroke and Non-CNS Systemic Embolism in Non-Valvular Atrial Fibrillation | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) FI (Completed) NL (Completed) DK (Completed) BE (Completed) HU (Completed) SE (Completed) LT (Completed) GB (Completed) CZ (Completed) FR (Completed) BG (Completed) GR (Completed) AT (Completed) IT (Completed) ES (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2012-002106-48 | Sponsor Protocol Number: BCF-2009.01 | Start Date*: 2012-07-06 |
Sponsor Name:University College Dublin | ||
Full Title: An Investigative Study to characterize gene expression patterns in myeloid cells that are triggered during acute asthma exacerbations, and to identify associated genes/gene networks that are Omaliz... | ||
Medical condition: Asthma | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: IE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2014-004249-29 | Sponsor Protocol Number: DALMATION/7212 | Start Date*: 2015-10-30 |
Sponsor Name:The Newcastle Upon Tyne Hospitals NHS Foundation Trust | ||
Full Title: An Open Label, Non-Randomised, Phase II study to Determine if Dabigatran and its Metabolites are Detectable in Breast Milk Following Oral Administration to Non-Breastfeeding Mothers | ||
Medical condition: Future use for VTE prophylaxis. | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: GB (Completed) | ||
Trial results: View results |
EudraCT Number: 2011-003473-29 | Sponsor Protocol Number: Uni-Koeln-1488 | Start Date*: 2012-11-19 | |||||||||||
Sponsor Name:University of Cologne | |||||||||||||
Full Title: Trial on treatment with inhaled furosemide of preterm and term neonates with transient tachypnoea | |||||||||||||
Medical condition: In this study we will prospectively analyze the benefit of inhaled furosemide for preterm and term neonates with transient tachypnoea. Patients received nebulised Furosemide iv solution 1 mg/kg or ... | |||||||||||||
|
|||||||||||||
Population Age: Preterm newborn infants, Newborns, Under 18 | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2008-004921-40 | Sponsor Protocol Number: 004SC08166 | Start Date*: 2008-12-09 | |||||||||||
Sponsor Name:ANGELINI | |||||||||||||
Full Title: A pilot study to evaluate the efficacy and safety of different bindarit dosages in preventing stent restenosis | |||||||||||||
Medical condition: PATIENTS WITH BARE METAL STENT IMPLANT | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2005-003745-14 | Sponsor Protocol Number: D1448C00005 | Start Date*: 2006-01-13 |
Sponsor Name:AstraZeneca AB | ||
Full Title: A Multi-centre, Double-blind, Randomised Withdrawal, Parallel-group, Placebo-controlled Phase III Study of the Efficacy and Safety of Quetiapine Fumarate Sustained Release (Seroquel SR®) as Monothe... | ||
Medical condition: Maintenance treatment of patients with Major Depressive Disorder | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: GB (Completed) FI (Completed) SK (Completed) DE (Completed) | ||
Trial results: View results |
EudraCT Number: 2008-002066-57 | Sponsor Protocol Number: 3151A6-2000 | Start Date*: 2015-04-03 |
Sponsor Name:Wyeth Research | ||
Full Title: Multicenter, Open-Label, Safety, Tolerability, and Pharmacokinetic Study to Evaluate Single Ascending Doses and Subsequent Short-Term Administration of Fixed Doses of Desvenlafaxine Succinate Susta... | ||
Medical condition: Major Depressive Disorder | ||
Disease: | ||
Population Age: Children, Under 18 | Gender: Male, Female | |
Trial protocol: Outside EU/EEA | ||
Trial results: View results |
EudraCT Number: 2006-006962-41 | Sponsor Protocol Number: CSTI571ADE60 | Start Date*: 2008-03-27 |
Sponsor Name:Charité Universitätsmedizin Berlin | ||
Full Title: Dendritic cells as autologous vaccine in patients with chronic myeloid leukemia | ||
Medical condition: Chronic myeloid leukemia is a malignant disease of the blood. Without therapy it has an unfavourable prognosis. Under first-line therapy with newer inhibitors of the thymidinkinase some few patien... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: DE (Prematurely Ended) | ||
Trial results: View results |
EudraCT Number: 2018-003458-26 | Sponsor Protocol Number: DEBATE | Start Date*: 2019-03-25 | |||||||||||
Sponsor Name:AZIENDA OSPEDALIERO-UNIVERSITARIA DI MODENA | |||||||||||||
Full Title: Evaluating inflammatory and immunological changes of HIV-positive patients switching to DTG dual regimen compared to those switching to a triple drugs regimen (B/F/TAF). | |||||||||||||
Medical condition: HIV infection | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: IT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2020-000247-32 | Sponsor Protocol Number: MAXINOVO | Start Date*: 2020-11-03 |
Sponsor Name:REPRODUCCION BILBAO (GINEGORAMA SL) | ||
Full Title: ACTIVATION OF PRIMORDIAL FOLLICULES AMONG WOMEN WITH POOR OVARIAN RESERVE BY USIN GROWTH FACTORS. | ||
Medical condition: The reproductive capacity of women depends on two factors: the number of follicles in the ovaries and the quality of oocytes within those follicles. Premature ovarian failure (POF) and poor ovaria... | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2015-005811-34 | Sponsor Protocol Number: 24d005 | Start Date*: 2018-07-05 |
Sponsor Name:VU Medical Center, Amsterdam | ||
Full Title: Pregnancy reLated Acute hyperTension INtervention Action: a randomized trial comparing labetalol and nicardipine in women with acute hypertension in pregnancy (Platina-trial) | ||
Medical condition: To asses optimal treatment of hypertension of hypertensive disorders in pregnancy | ||
Disease: | ||
Population Age: Adults | Gender: Female | |
Trial protocol: NL (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2013-000280-84 | Sponsor Protocol Number: ML28882 | Start Date*: 2013-08-15 |
Sponsor Name:Finnish melanoma group | ||
Full Title: COBRA: TOL+ INTERFERON-alpha COMBINED WITH VEMURAFENIB (BRAF-mutation positive patients) OR TOL + INTERFERON- alpha (BRAF-mutation negative patients) FOR PATIENTS WITH ADVANCED MELANOMA AS 1st CHEM... | ||
Medical condition: Patients with histologically confirmed metastatic melanoma | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000692-32 | Sponsor Protocol Number: FARMPre-Proposalcode:TRS-2016-00 | Start Date*: 2019-07-17 | ||||||||||||||||
Sponsor Name:DIP. MEDICINA DEI SISTEMI UNIVERSITà DEGLI STUDI DI ROMA TOR VERGATA | ||||||||||||||||||
Full Title: EFFICACY OF METFORMIN ON MOTILITY AND STRENGTH IN MYOTONIC DYSTROPHY TYPE 1. A randomized, double blind, placebo-controlled, multicenter clinical trial. | ||||||||||||||||||
Medical condition: Myotonic Distrophy type 1, confirmed by genetic testing, with a CTG expansion size >100 | ||||||||||||||||||
|
||||||||||||||||||
Population Age: Adults | Gender: Male, Female | |||||||||||||||||
Trial protocol: IT (Completed) | ||||||||||||||||||
Trial results: (No results available) |
Subscribe to this Search
To subscribe to the RSS feed for this search click here
.
This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here

Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
